Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12002923Phase 4Completed
Phase 4 trial of levobupivacaine and bupivacaine (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Successful response. Started May 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12002923.